Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Introducing the Nu.Q® Vet Cancer Test

Key Takeaway: Volition has introduced the Nu.Q® Vet Cancer Test, aimed at early detection of cancer in dogs, which is crucial for improving treatment outcomes. The test highlights the alarming statistic that 50% of dogs will be diagnosed with cancer in their lifetime. Additionally, a manuscript for a similar test in cats has been submitted, potentially unlocking a $5 million milestone payment.
Price reaction · baseline $14.402 (2024-05-22T13:41:00.000Z) · hit during market hours · clean, no other VNRX news in the window
day 0 close · peak
+0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Introduction of the Nu.Q® Vet Cancer Test for early detection.
  • Potential to improve outcomes for dogs diagnosed with cancer.
  • Collaboration with Fujifilm Vet Systems for automation.

Full Press Release Details

Did you know that cancer is the leading cause of death in dogs over the age of two? 50% of all dogs will be diagnosed with cancer in their lifetimes. As with humans, early detection is key for better outcomes in these dogs. Watch this short video, featuring Volition CMO Heather Wilson-Robles , as she introduces our Nu.Q ® Vet Cancer Test and its benefits.

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is designed for early detection of cancer in dogs.

Why is early detection important for dogs?

Early detection is crucial as it significantly improves treatment outcomes for dogs.

What percentage of dogs are diagnosed with cancer?

50% of all dogs will be diagnosed with cancer in their lifetimes.

What milestone payment is associated with the test?

The publication of a related manuscript for cats may unlock a $5 million milestone payment.

Last updated: May 22, 2024